Areas of human research

Types of evidence
Design Useful question Main limitation
Acute metabolic experiment Does a response change over hours? Does not establish a sustained body-composition outcome.
Controlled intervention Does a defined treatment differ from placebo? Results depend on the participants and duration.
Pharmacokinetic study How do concentrations change with time? Concentration alone does not describe every clinical effect.
Poison-center series Which problems occur in reported exposures? Cannot calculate risk among all users.

Thermogenesis and glucose uptake

Jessen et al. (2020) measured acute changes in resting expenditure, substrate use and muscle signaling in six men. The study demonstrates a short-term physiological response, rather than a completed weight-loss outcome.

In van Beek et al. (2023), primary analyses in 11 healthy young men found a 13% improvement in insulin-stimulated peripheral glucose disposal after two weeks compared with placebo. A clamp test controlled glucose and insulin during measurement.

Improved glucose disposal under those conditions does not establish a treatment for diabetes. Acute adrenergic effects can differ from responses after repeated exposure, and systemic cardiovascular effects remain relevant.

Muscle adaptation

Resistance exercise changes muscle through mechanical loading and repeated adaptation. Trials combining a drug with training must compare against the same training without the active drug.

The human muscle trials distinguish lean tissue, lifting outcomes and aerobic capacity. These endpoints answer more specific questions than a claim that a substance improves performance overall.

Bronchodilation

An older double-blind crossover study in asthma measured peak expiratory flow after bronchodilator treatment. This endpoint reflects how quickly air can be expelled from the lungs.

Respiratory benefit depends on reversible narrowing. Airway inflammation requires separate consideration, and an oral bronchodilator is not an emergency substitute during a severe acute attack.

Clinical observations of toxicity

Spiller and colleagues described reported adverse exposures involving cardiovascular symptoms, metabolic abnormalities and prolonged effects. These observations help identify complications requiring assessment.

People reaching a poison service are a selected group. The proportion hospitalized in such a series cannot be interpreted as the probability of hospitalization for every exposed person.

Absorption and elimination

Pharmacokinetic studies follow a substance through absorption and elimination. The early plasma and urine study helps explain why repeated exposure and next-day effects are plausible.

The duration of a clinical effect also depends on tissue sensitivity and any complication. Duration of action separates these issues from laboratory detection.